Drug
Elsubrutinib clinical trials
Also written ABBV-105.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
4 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses elsubrutinib is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease StateCompletedPhase 2AbbVieNCT04451772Written as Elsubrutinib
- A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)CompletedPhase 2AbbVieNCT03978520Written as Elsubrutinib
- A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With UpadacitinibTerminatedPhase 2AbbVieNCT03823378Written as Elsubrutinib
- A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid ArthritisCompletedPhase 2AbbVieNCT03682705Written as Elsubrutinib
Codes
What other systems call elsubrutinib · ClinicalTrials.gg INT014275
- UNII (FDA) 1487U1Q3IQELSUBRUTINIBConfirmed FDA, Wikidata
- Wikidata Q105335278elsubrutinibConfirmed FDA, Wikidata
- NCI Thesaurus C175777ElsubrutinibOne source FDA
- DrugBank DB18850One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 1487U1Q3IQ | ELSUBRUTINIB | Confirmed FDA, Wikidata |
| Wikidata | Q105335278 | elsubrutinib | Confirmed FDA, Wikidata |
| NCI Thesaurus | C175777 | Elsubrutinib | One source FDA |
| DrugBank | DB18850 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.